Literature DB >> 7651736

Distance constraints and stereospecific alignment requirements characteristic of p53 DNA-binding consensus sequence homologies.

J L Cook1, R N Ré, J F Giardina, F E Fontenot, D Y Cheng, J Alam.   

Abstract

We present evidence in favor of the position that some mutant p53 proteins retain the ability to trans-activate downstream genes through p53 DNA-binding consensus sequence (CS) homologies. We tested one cell line possessing high levels of mutant p53 and found that this mutant p53 is highly active in trans-activating one CS homology, moderately active in trans-activating a second sequence and inactive in modulating a third sequence. We tested a second cell line, also possessing high levels of mutant p53 and found the same pattern of activation. In addition we find that inter-motif distance [represented by N in RRRCWWGYYY(N)RRRCWWGYYY] is very important in determining the relative binding affinity of a given CS homology for wild-type or mutant p53. Our studies suggest that stereospecific alignment of the DNA-binding motifs within the CS may favor binding of wild-type p53 while misalignment may favor binding of mutant p53. Furthermore, we find that the maximum distances at which p53 DNA-binding CS homologies are functionally active vary for different sequences. Introduction of as few as 200 bp between one CS homology and the downstream TATA box can eliminate a 45-fold p53-mediated transactivation. We present evidence that the composition of the DNA which flanks a p53 DNA-binding consensus sequence may also modulate trans-activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651736

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Inhibition of Erythroleukemia Cell Growth by Triplex-forming RNAs.

Authors:  Richard N Re; Zhuo Zhang; Julia L Cook
Journal:  Ochsner J       Date:  2007

2.  Tubulin polymerization promoting protein 1 (TPPP1): A DNA-damage induced microtubule regulatory gene.

Authors:  Alice Schofield; Ora Bernard
Journal:  Commun Integr Biol       Date:  2013-09-05

3.  Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic.

Authors:  Annelien Verfaillie; Dmitry Svetlichnyy; Hana Imrichova; Kristofer Davie; Mark Fiers; Zeynep Kalender Atak; Gert Hulselmans; Valerie Christiaens; Stein Aerts
Journal:  Genome Res       Date:  2016-05-18       Impact factor: 9.043

4.  FOXP1 and NDRG1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions.

Authors:  Sunil K Panigrahi; Constantinos G Broustas; Ping Q Cuiper; Renu K Virk; Howard B Lieberman
Journal:  Cell Signal       Date:  2021-07-21       Impact factor: 4.850

5.  Regression based predictor for p53 transactivation.

Authors:  Sivakumar Gowrisankar; Anil G Jegga
Journal:  BMC Bioinformatics       Date:  2009-07-14       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.